Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7.

Abstract

OBJECTIVE To compare the cost implications of treatment of persistent fracture non-unions before and after application of recombinant human bone morphogenetic protein-7 (BMP-7). METHOD Of 25 fracture non-unions, 9 were treated using BMP-7 alone and 16 using BMP-7 and bone grafting. These patients were prospectively followed up, and the costs incurred were… (More)

Topics

  • Presentations referencing similar topics